Ignite Creation Date:
2025-12-24 @ 1:15 PM
Ignite Modification Date:
2025-12-27 @ 9:21 PM
Study NCT ID:
NCT00807495
Status:
COMPLETED
Last Update Posted:
2018-03-27
First Post:
2008-12-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-02-10
Start Date Type:
ACTUAL
Primary Completion Date:
2011-01-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-02-13
Completion Date Type:
ACTUAL
First Submit Date:
2008-12-11
First Submit QC Date:
None
Study First Post Date:
2008-12-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-01-04
Results First Submit QC Date:
None
Results First Post Date:
2018-03-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-06-29
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-02-27
Last Update Post Date:
2018-03-27
Last Update Post Date Type:
ACTUAL